LONDON - Cambridge Antibody Technology plc had a cheery start to the New Year with news that partner Abbott Laboratories Inc. received FDA approval earlier than anticipated to market Humira for rheumatoid arthritis, and the drug will begin shipping this month. (BioWorld International)

LONDON - Cambridge Antibody Technology plc had a cheery start to the New Year with news that partner Abbott Laboratories Inc. received FDA approval earlier than anticipated to market Humira for rheumatoid arthritis, and the drug will begin shipping this month. (BioWorld International)

Proteome Sciences plc claimed it would be the first to commercialize a product based on proteomics when it announced a deal to use its protein biomarkers for stroke in point-of-care diagnostic equipment. (Bioworld International)